News

BioM's articles and press releases about the Bavarian biotechnology sector


m4 Award 2025: 2.5 million euros for five research teams from Bavaria

m4 Award for pre-seed start-ups goes to in­nov­at­ive re­search on Alzheimer's, can­cer, RNA ther­apy and rheum­at­oid arth­rit­is. The five…

Foundation stone laid in Penzberg: Roche builds new laboratory for modern sequencing technology to research complex diseases

Roche has given the of­fi­cial start­ing sig­nal for a new labor­at­ory build­ing at the Pen­zberg site with a ce­re­mo­ni­al lay­ing of the…

BayOConnect 2025 - Preview of Day 2: Accelerating innovation - new solutions with AI, start-ups and biotech investments in transition

After a first con­fer­ence day filled with glob­al per­spect­ives and stra­tegic in­sights, BayOCon­nect 2025 will turn its focus to…

Munich researchers receive ERC Advanced Grant and thus millions in funding for research into diseases such as ALS, Alzheimer's and atherosclerosis

Di­eter Ed­bauer, Tho­mas Korn, and Chris­ti­an Weber re­ceived the pres­ti­gi­ous ERC Ad­vanced Grant from the  European Re­search Coun­cil…

Nordic Life Science Days 2025: Secure your discount on tickets with the BioM promo code!

Nord­ic Life Science Days (NLS Days) is the lead­ing part­ner­ing and in­vestor con­fer­ence for the life sci­ence in­dustry in North­ern…

m4 Award winner Mallia closes EUR 5.5 million financing and sets strategic course for the future

Mal­lia In­nov­a­tions GmbH, formerly Mal­lia Thera­peut­ics, has com­pleted fin­an­cing of 5.5 mil­lion euros and is re­or­gan­iz­ing…

AI for Health Symposium 2025 at Helmholtz Munich

On Fri­day 4 July 2025, the Helm­holtz Mu­nich will host the "AI for Health Sym­posi­um 2025" – a sym­posi­um on the use of gen­er­at­ive AI…

Immunic secures USD 65 million with the prospect of more

The NASDAQ-lis­ted bi­otech com­pany Im­mu­nic from Gräfelf­ing an­nounces the suc­cess­ful com­ple­tion of an over­sub­scribed cap­it­al…

Biotech in Bavaria: Record investments and stable development

BioM pub­lishes an­nu­al re­port “Bi­otech in Bav­aria 2024/25” Re­cord fin­an­cing of over 910 mil­lion eurosS­light in­crease to 540…

BayOConnect 2025 – Preview of Day 1: Global Perspectives, Strategic Alliances and Innovation in Focus

The count­down is on: On 1-2 July, Bay­oCon­nect 2025 will once again bring to­geth­er key stake­hold­ers from bi­otech, pharma, aca­demia,…

Newsletter

Subscribe

Archive



Publish press release

 To the login


Gabriele Klingner
Gabriele Klingner

Communications & Marketing Lead


Christiane Proll
Christiane Proll

PR & Social Media Manager